Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Hampshire for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Hampshire only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Hampshire (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Reisman (NPI 1285710152)

Field	Value
Entity Type	Individual
Organization	David Reisman
Address	87 Mcgregor St
City	Manchester
State	NH
ZIP	03102
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	October 31, 2006

Payer Source	Total Paid
Medicare	$366.8K
Medicaid	$0

Key Findings

This provider’s Medicare business is modest in scale: Total Medicare revenue is $366.8K while Medicaid billing is reported as none, so the practice is effectively single‑payer (Medicare) in the available data. The NPI was enumerated on 2006-10-31 (~20 years ago), indicating long tenure which supports an established local practice footprint despite the relatively small Medicare revenue total.

Revenue concentration is high: precomputed top 3 Medicare codes by revenue account for 72.6% of this provider's total Medicare revenue. J0897 alone represents $208.4K (57.1% of Medicare revenue), with 99214 at $32.1K (8.8%) and J1437 at $24.3K (6.7%), so these three codes dominate the payer mix and should be the focus for payer contracting or utilization review.

The code mix indicates an infusion‑centric hematology/oncology practice with a strong emphasis on specialty injectable therapies rather than high volumes of evaluation & management alone. J0897 (denosumab) and J1437 (ferric derisomaltose) are the top drivers by revenue, and chemotherapy administration codes such as 96413, 96401 and add‑on/infusion codes (96417, 96367, 96365) are present at lower revenue levels, consistent with an outpatient infusion/service line rather than a pure office‑visit practice.

Competitive standing is mixed across codes: for the top revenue driver J0897 the provider ranks #887 of 10057 nationally (91th percentile) with a label of typical, unremarkable volume, indicating they are above median but not an outlier nationally for that drug. By contrast J1437 ranks #495 of 581 (15th percentile) and is reported as typical, unremarkable volume relative to a much smaller national cohort for that code, suggesting relatively low standing for ferric derisomaltose compared with the narrow peer group.

Several evaluation & management codes appear as meaningful secondary revenue sources but at modest levels versus infusions: 99214 generated $32.1K (8.8%) and 99215 generated $22.4K (6.1%) of Medicare revenue, and 99213 and new‑patient codes are present at lower revenue. National rank/percentiles for these E/M codes (for example 99214 at #82175 of 479517, 83th percentile) show the provider is a typical/above‑median user of mid‑level E/M visits, consistent with ongoing follow‑up care tied to infusion services.

There are notable high‑volume/low‑revenue supply or ancillary codes on file that merit attention: J1100 shows 3.2K claims with $0 avg paid/claim and $0 revenue yet ranks #880 of 23460 (96th percentile) and is flagged as notably above typical national volume. Similarly, J2469 (palonosetron) appears with 960 claims but only $960 revenue. These patterns reflect substantial claim activity for certain injectable supplies or antiemetics that produce little direct Medicare revenue and may reflect billing practices tied to bundled administration or payer contract terms.

A couple of procedural codes are national outliers in utilization: 36591 (blood draw from an implanted venous access device) generated $3.4K and the provider ranks #26 of 699 (96th percentile), described as notably above typical national volume. That elevated use of port/implant access services aligns with an infusion/heme‑oncology clinic profile and may indicate a higher per‑patient intensity of infusion procedures or a patient panel that frequently receives port‑based therapies.

Chemotherapy administration codes are present but not dominant: 96413 produced $18.3K (5.0%) and other chemo administration entries (96401, 96402, 96417) contribute smaller shares. Ranks for these codes are generally in the middle of national distributions (for example 96413 at the 58th percentile), implying the provider delivers standard chemotherapy/infusion services at typical volumes for a community hematology/oncology practice rather than operating at a high‑volume oncology center.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0897	Injection, denosumab, 1 mg	11,580	$20	$208.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	350	$90	$32.1K
J1437	Injection, ferric derisomaltose, 10 mg	1,430	$20	$24.3K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	170	$130	$22.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	190	$100	$18.3K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	110	$140	$14.8K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	180	$50	$9.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	150	$50	$7.3K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	100	$50	$4.9K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	200	$20	$4.3K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Hampshire Distribution

David Reisman — 2 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Hampshire

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0897	2	20	2,760	$20	$75.4K
J1437	1	10	1,430	$20	$24.5K
J9217	4	10	100	$130	$16.4K
96413	10	20	140	$100	$15.8K
99214	407	3,150	110	$80	$13.2K
99233	604	600	70	$90	$10.9K
99213	790	2,900	70	$50	$6.9K
99215	80	1,080	40	$110	$6.8K
96401	1	10	70	$50	$5.1K
99205	376	440	20	$140	$4.9K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Reisman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
North Memorial Health Care	MN	Ambulance	$0	$112.8M
Fairview Health Services	MN	General Acute Care Hospital	$0	$90.4M
Firsthealth Of The Carolinas, Inc.	NC	General Acute Care Hospital	$0	$61.5M
Benefis Hospitals Inc	MT	Multi-Specialty Clinic/Center	$0	$38.2M
West Mont	MT	Adult Care Home Facility	$0	$34.7M
Fairview Express Care	MN	Specialist	$0	$33.1M
North Memorial Health Care	MN	General Acute Care Hospital	$0	$32.5M
Union Associated Physicians Clinic, LLC	IN	Family Medicine Physician	$0	$31.1M
Fairview Health Services	MN	General Acute Care Hospital	$0	$30M
Fairview Health Services	MN	Emergency Medicine Physician	$0	$26.6M

Nearby Providers

Other providers in the same ZIP code as David Reisman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Moore Center Services, Inc.	NH	Early Intervention Provider Agency	$0	$373.9M
Catholic Medical Center	NH	General Acute Care Hospital	$0	$19.8M
Manchester School District	NH	Local Education Agency (LEA)	$0	$4M
Amoskeag Health	NH	Federally Qualified Health Center (FQHC)	$0	$3.1M
Paul Degregorio	NH	Retina Specialist (Ophthalmology) Physician	$1.9M	$0
Metro Treatment Of New Hampshire LP	NH	Methadone Clinic	$148.8K	$1.6M
Anthony Correnti	NH	Ophthalmology Physician	$1.5M	$0
Home For Butterflies, LLC	NH	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$1.4M
Nancy Efferson-bonachea	NH	Ophthalmology Physician	$790.7K	$0
Nh Eye Associates PLLC	NH	Ophthalmology Physician	$0	$739K

David Reisman — Billing Profile & Reimbursement Data

Sign up for David Reisman — Billing Profile & Reimbursement Data policy alerts

David Reisman — Billing Profile & Reimbursement Data

Sign up for David Reisman — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References